ORKA
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Oruka Therapeutics reports positive Week 28 ORKA-001 data from the ongoing EVERLAST-A trial, showing deeper responses without additional dosingSep 23, 2026
- Oruka Therapeutics reported positive week 16 data for ORKA-001 from the ongoing EVERLAST-A Phase 2a trial in plaque psoriasisApr 27, 2026
- Oruka Therapeutics announced positive Phase 1 data for ORKA-002 and started EVERLAST-B trialJan 12, 2026
- Oruka Therapeutics announces positive interim Phase 1 results for ORKA-001Sep 17, 2025
- Oruka Therapeutics announces IND clearance for EVERLAST-A Phase 2a trial of ORKA-001 in psoriasis, with Phase 1 data to be presented at EADV in SeptemberJul 21, 2025